Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 to 80

Comparing oral and intratympanic corticosteroids for sudden hearing loss

Official title: Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing Loss

Run by Dr. Lutfi Kirdar Kartal Training and Research Hospital · NCT06968507 · Data updated 2026-11-12

This study is testing whether taking corticosteroids by mouth or getting them through an injection in the ear works better for people with sudden hearing loss.

More Sensorineural Hearing Loss trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment214 (estimated)
SponsorDr. Lutfi Kirdar Kartal Training and Research Hospital
Government
Drugs / interventionschemotherapy
Locations1 site (Istanbul, Kartal)
StatusRecruiting
StartedDecember 25, 2024
Main results expectedSeptember 10, 2028
Study endsSeptember 10, 2028
Registry record updatedSeptember 1, 2026
Trial IDNCT06968507 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 80 with unilateral sudden sensorineural hearing loss that developed within the last 72 hours.

Probably not a fit

Patients with a history of hearing-related surgery, chronic ear diseases, or other specified exclusion criteria may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine the effectiveness of two corticosteroid treatment methods for patients with sudden sensorineural hearing loss: oral methylprednisolone and intratympanic dexamethasone. Participants will be divided into two groups, with one receiving oral medication and the other receiving intratympanic injections over a specified treatment period. Follow-up visits will occur at regular intervals to assess hearing recovery and overall outcomes. The study seeks to provide clarity on which treatment option yields better results for patients experiencing this condition.

Why it matters

Potential benefit: If successful, this study could identify a more effective treatment option for sudden sensorineural hearing loss, potentially improving patient outcomes.

How similar studies have gone: Previous studies have explored corticosteroid treatments for hearing loss, but this specific comparison of oral versus intratympanic administration is less common, making it a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years of age and older
* Unilateral sudden sensorineural hearing loss that developed within 72 hours and has lasted for 14 days or less
* Affected side PTA (500-100-2000-4000hz) should be over 50dB
* Affected side should be at least 30dB lower than healthy side in 3 frequencies
* Hearing should be symmetrical according to patient's statement before sensorineural hearing loss
* If used, steroid use should be less than 10 days
* Cerebellar and vestibular examination should be normal

Exclusion Criteria:

* Having a history of hearing-related surgery other than a ventilation tube
* Having a history of previous hearing loss, fluctuating hearing or Meniere's disease, chronic inflammatory or suppurative ear disease or cholesteatoma, otosclerosis
* Being under 18 or over 80
* Having a history of physical-barotrauma
* Presence of structural or retrocochlear pathology in the examination and imaging that would explain the unilateral hearing loss
* Patients diagnosed with tuberculosis or receiving prophylactic tuberculosis treatment, diabetes mellitus, rheumatological patients, those with atherosclerotic disease, serious psychiatric patients, those receiving chemotherapy, radiotherapy or immunosuppressant treatment, pancreatitis patients, HIV, hepatitis C and B patients, those with chronic renal failure, substance abusers, those with active herpetic lesions, severe osteoporosis patients, those with hearing loss within 4 weeks after general anesthesia, those with a history of head and neck cancer.

Where it's running

  • Dr Lütfi Kırdar City Hospital
    Istanbul, Kartal, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.